Skip to main content
Publication date
2019 08
Authors
Spiliopoulou, A Colombo, M Plant, D Nair, N Cui, J Coenen, MJH Ikari, K Yamanaka, H Saevarsdottir, S Padyukov, L Bridges, SL Kimberly, RP Okada, Y van Riel, PLCM Wolbink, G van der Horst-Bruinsma, IE de Vries, N Tak, PP Ohmura, K Canhao, H Guchelaar, HJ Huizinga, TWJ Criswell, LA Raychaudhuri, S Weinblatt, ME Wilson, AG Mariette, X Isaacs, JD Morgan, AW Pitzalis, C Barton, A McKeigue, P
Author KI Usernames
Padyukov, L|leopad Saevarsdottir, S|saesae
Pubmed ID
31036624
Journal
Annals of the rheumatic diseases
Doctype
Article
KI Connection
Låg
Mesh SV
Antireumatiska medel Apyras Behandlingsresultat Biologiska produkter CD40-antigener CD-antigener Genome-Wide Association Study Kohortstudier Kvinnlig Ledgångsreumatism Manlig Medelålders personer Multivariantanalys Människa Prediktivt värde av tester Prognos QTL Reglering av genuttryck Regressionsanalys Riktad molekylär behandling Vuxna Äldre
Mesh EN
Antigens, CD Antirheumatic Agents Apyrase Arthritis, Rheumatoid Biological Products CD40 Antigens Cohort Studies Gene Expression Regulation Genome-Wide Association Study Molecular Targeted Therapy Multivariate Analysis Predictive Value of Tests Prognosis Quantitative Trait Loci Regression Analysis Treatment Outcome Tumor Necrosis Factor Inhibitors
First date
2019-09-29T04:33:46.96Z